EUVIMEDEUVIMED entdecken
Crossref

Superior In Vivo Efficacy of Fermented Over Aqueous Astragalus membranaceus in Diabetic Nephropathy: A Systematic Pharmacological Evaluation and Mechanistic Study

Rui Wu, Guangzhe Yao, Huizhen Zhao, Shufeng Zhang, Chao Li, Guangyuan Li, Guoming Wang iD

Biomedical Chromatography · 2026-06 · 40 (6)

DOI: 10.1002/bmc.70449 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 20.04.2026. Verfasst von Rui Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: CangZhou Medical College, Hebei, China. Hauptthemen laut MEDLINE: Astragalus propinquus, Diabetic Nephropathies, Plant Extracts. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Self-funded Project of Cangzhou Science and Technology Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic nephropathy (DN) is a major microvascular complication of diabetes and a leading cause of end‐stage renal disease, with current treatments failing to halt progression, creating demand for better interventions. Astragalus membranaceus shows promise for DN, and microbial fermentation enhances herbal bioavailability and efficacy. This study compared fermented A. membranaceus broth (FA) and its aqueous extract (EA) in streptozotocin‐induced DN rats, with 8‐week low/medium/high‐dose treatment. FA outperformed EA in improving metabolic parameters and renal function: superior body weight recovery, greater reductions in fasting blood glucose, serum BUN, ALT, and TG, enhanced renal antioxidant capacity (elevated SOD/GSH‐Px and reduced MDA), and alleviated glomerular/tubular injury and interstitial inflammation. Chemical profiling identified 14 FA bioactive components; network pharmacology revealed core targets (STAT3, IL6, and TGFB1) and key pathways (AGE‐RAGE, HIF‐1, and FoxO). Fermentation boosts A. membranaceus efficacy in DN via better active constituent bioavailability, conferring stronger antioxidant, metabolic, and renoprotective effects, making FA a promising therapeutic and bioprocessing a strategy to upgrade traditional herbs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Astragalus propinquusDiabetic NephropathiesPlant ExtractsAnimalsFermentationRatsMaleRats, Sprague-DawleyDiabetes Mellitus, ExperimentalAntioxidants

Stichwörter der Autor:innen

Astragalus membranaceusdiabetic nephropathyfermentationnetwork pharmacologyoxidative stress

Substanzen

Plant ExtractsAntioxidants

Autor:innen und Institutionen

  • CangZhou Medical College, Hebei, China.

ORCID-Profile: Guoming Wang

Förderung

  • Self-funded Project of Cangzhou Science and Technology Plan

Zitieren

APA

Wu, R., Yao, G., Zhao, H., Zhang, S., Li, C., Li, G., & Wang, G. (2026). Superior In Vivo Efficacy of Fermented Over Aqueous Astragalus membranaceus in Diabetic Nephropathy: A Systematic Pharmacological Evaluation and Mechanistic Study. Biomedical Chromatography, 40(6). https://doi.org/10.1002/bmc.70449

Vancouver

Wu R, Yao G, Zhao H, Zhang S, Li C, Li G, et al. Superior In Vivo Efficacy of Fermented Over Aqueous Astragalus membranaceus in Diabetic Nephropathy: A Systematic Pharmacological Evaluation and Mechanistic Study. Biomedical Chromatography. 2026;40(6). doi:10.1002/bmc.70449

BibTeX
@article{Wu2026,
  author = {Wu, Rui and Yao, Guangzhe and Zhao, Huizhen and Zhang, Shufeng and Li, Chao and Li, Guangyuan and Wang, Guoming},
  title = {Superior In Vivo Efficacy of Fermented Over Aqueous Astragalus membranaceus in Diabetic Nephropathy: A Systematic Pharmacological Evaluation and Mechanistic Study},
  journal = {Biomedical Chromatography},
  year = {2026},
  volume = {40},
  number = {6},
  doi = {10.1002/bmc.70449}
}
Kostenlos starten →